|
Registration benefits include:
|
|
Access to CME/CE programs and certification
|
|
|
Free subscription to Biologic Bulletin newsletter
|
|
|
Reminders of new CME/CE activities
|
 REGISTER NOW
|
|
This Web site is supported by an
unrestricted educational grant from
Genentech, Inc.
|
|
|
|
 |
| CME/CE Programs : CE Programs : New Treatment for Psoriasis: From the Inside Out |
|
Faculty
Pat McClelland, RN
UCSF Psoriasis and Skin Treatment Center
UCSF Medical Center
San Francisco, California
Robin Weber, RN, MN, FNP-C
VA Medical Center
Portland, Oregon
Melodie Young, MSN, RN, A/GNP-C
Texas Dermatology Associates
Dallas, Texas
Acknowledgement
Supported by an unrestricted educational grant from Genentech.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain the prevalence of psoriasis.
- Identify new thinking on the pathogenesis of psoriasis.
- Describe the immunological basis of psoriasis.
- Discuss quality-of-life issues in patients with psoriasis, including
the economic impact.
- Identify new biologic treatments for psoriasis.
Target Audience
Registered nurses treating patients with moderate to severe psoriasis and related immunologic disorders, and others interested in the care of patients with psoriasis.
Description
In this activity, expert speakers will discuss the revolution in understanding of the pathophysiology of psoriasis. Developments of biologic treatments are offering improved outcomes and quality of life for patients. The speakers will describe new research on immune system function and innovative treatment modalities.
Purpose
Provide the latest information on the immunologic basis of psoriasis and use of new biologics to improve patient outcomes.
CNA/ANCC
This educational activity for 1.5 contact hours is provided by the Postgraduate Institute for Medicine. The Postgraduate Institute for Medicine is an approved provider of continuing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
California Board of Registered Nursing
The Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485, for 1.5 contact hours.
Instructions for Obtaining CE Credit
To receive credit for completing this educational program:
- View the CE presentation.
- Complete the post-test/evaluation and return to:
Postgraduate Institute for Medicine
P.O. Box 260620
Littleton, CO 80163
Fax: 303-790-4876
Faculty Disclosures
Pat McClelland, RN, has served as a speaker to Amgen, Biogen, and ICN Pharmaceuticals and is a member of the nurse advisory board for Amgen, Biogen, and Genentech.
Robin Weber, RN, MN, FNP-C, disclosed having no significant financial relationships with commercial entities related to her presentation materials.
Melodie Young, MSN, RN, A/GNP-C, has served as a speaker to Genentech, and is a member of the nurse advisory board for Genentech.
|
|
|
|
